Beautify your patient’s appearance by reducing under eye hollows with Redensity 2**
When I chose a product, first I look at the safety. But my second concern is that I want a product that fits really well this area, and so I love to have a dedicated product.
1ST AND ONLY HYALURONIC ACID GEL DESIGNED FOR THE TEAR TROUGH1-3
98% of patients would recommend tear trough procedure
99% of patients and physicians perceived an aesthetic improvement***
The tear trough is a cavity that must be lightly filled to avoid overcorrection and reduce risk of safety issues.
1. Thin skin
2. Infraorbital fat (IOF)
3. Orbicularis oculi muscle
4. Hyaluronic acid gel
REDENSITY 2** profile combines light consistency, low hygroscopy, good spreadability and good safety profile which all together will allow you to easily achieve natural results2-6
Discover TEOXANE multi-products approach
Combining RHA 4** for soft volume enhancement in the midface7,8 and REDENSITY 2** specifically designed to treat the under eye hollows1-3 allows you to offer a comprehensive treatment plan meeting your patients needs.9
Discover our dedicated webinars on the periorbital area
BRIGHTENS THE EYE CONTOUR
Boost your patient satisfaction with the ideal complement to REDENSITY 2**
70% of women noticed brighter skin after 28 days of use10
*Teoxane internal data (PMS data + Clinical study: TEO-MDR-1901 A prospective, observational study of the routine of TEOSYAL® PureSense Redensity 2 for aesthetic treatment
**Redensity 2 = TEOSYAL® PureSense Redensity 2 , RHA 4 = TEOSYAL RHA® 4
*** 1 month after injection
TEOSYAL®PureSense Redensity 2 and TEOSYAL RHA® 4 are trademarks of the firm TEOXANE SA. These products are gels that contain hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local
anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/ or amide local anaesthetic agents, we recommend not to use lidocaine-containing
products and to refer to products without lidocaine. TEOSYAL® PureSense Redensity 2 and TEOSYAL RHA® 4 are class III medical devices and are regulated health product bearing the CE marking
(CE2797) under this regulation. For professional use only. Please refer to the Instructions For Use. Products availability depend on registration, please contact your local distributor. Please inform
the manufacturer TEOXANE of any side effect or any complaint as soon as possible to the following address: firstname.lastname@example.org.
1.TEOSYAL® PureSense Redensity 2 – Instructions for use.
2.Berguiga M, Galatoire O. Tear trough rejuvenation: a safety evaluation of the treatment by a semi-crosslinked Hyaluronic Acid filler. Orbit, 2017; 36 (1):22-26.
3.Anido et al. J Cosmet Dermatol. 2020;00:1–12.
4.Teoxane internal data source. Teosyal® PureSense Redensity 2 deliveries from 2012 to 2021: 2’735’192 syringes.
5.Data on File. RDRE 2023-Physical analysis of HA fillers intended for infraorbital uses.
6.Park Y et al. Hyaluronic acid filler combined with antioxidants for infraorbital rejuvenation: Report of two cases. Dermatol. Therapy. 2017
7.TEOSYAL RHA® 4 – instruction for use.
8.Data on file. TEOSYAL RHA® 4 keeps its mechanical properties on a large range of strain or stress constraints – Report Rheological characterizations of hyaluronic acid gels.
9.Teoxane Post Market Surveillance data November 2020. 1445 practitioners worldwide.
10.Self-assessment performed by independent laboratory on dark circles. 24 volunteers (12 sensitive skin and 12 normal skin) over 28 days. Results after 28 days of use.